Symphosium pre ASH 8 December 2017
FISM is the Italian Foundation of Myelodysplastic Syndromes
FISM coordinates research activities on myelodysplasic syndromes in Italy from many centers distributed throughout the country.
Newsletter
What about Myelodysplastic Syndromes
The term “myelodysplasia” comes from the Greek words: “myelo”, that is, blood cells, and “dysplasia”, ie abnormal growth or growth.
Myelodysplastic syndromes (MDS) are a heterogeneous group of blood pathologies where bone marrow cells can not become perfect and healthy cells but stop at an immature stage. The bone marrow therefore fails to produce enough red blood cells, white blood cells or healthy platelets.
These cells that remain at an immature stage are called “blasts”.
The incidence of this disease in Europe is about 8 people per 100,000 inhabitants. This is a disease affecting mainly elderly people: over 70, people affected by MDS are about 35 people per 100,000 inhabitants.
Most experts agree that myelodysplasies are a type of bone marrow and bone marrow that can occur in either chronic or aggressive form.
What can you do?
To continue our job to a future free from myelodysplasia, we need the help of everyone, even yours! Contribute to the scientific research that FISM brings forward every day, helps FISM to give to the patients a world where MDS are no longer scary.
Friend Links
Congresses and Events
No event found!